hey… what are you waiting for? yogadopa.com has new posts already!
–
This site (kaitlynroland.wordpress.com) will no longer be updated, so don’t forget to head over and sign-up on yogadopa.com to stay up-to-date with blog posts, research, presentations and events!
–
much love.
hey… exciting news!
come join me over at yogadopa.com.
–
This site (kaitlynroland.wordpress.com) will no longer be updated, so don’t forget to head over and sign-up on yogadopa.com to stay up-to-date with blog posts, research, presentations and events!
–
much love.
“In this study we sought to find a set of circulating molecules in the blood of individuals who were cognitively normal that would allow us to predict who in the next several years will develop cognitive impairement or Alzheimer’s disease, and that is exactly what we found“
Dr. Federoff at Georgetown University published research in the journal Nature Medicine that identified 10 molecules in the blood that could be used to predict with at least 90% accuracy whether people went on to develop mild cognitive impairment or Alzheimer’s. It is the first study to show differences in biomarkers in the blood between those who went on to suffer the disease, and those who remained “cognitively normal”.
If you could get a test to see if Alzheimer’s was in your future would you? This leads to ethical implications of a test that could predict a disease that currently has no cure. What do you think about this? Would you get tested? much love.
–
References:
The Current (episode March 12, 2014) http://www.cbc.ca/
Can vitamin E slow Alzheimer’s disease (AD) progression?
According to a new double-blind, placebo-controlled trial found that alpha tocopherol (2000IU/d vitamin E) reduced the rate of functional decline in 561 patients with mild to moderate AD.
In the vitamin E group, the delay in clinical progression of AD was translated to 19% per year compared with placebo or a delay of approximately 6.2 months over the follow-up period.
… do you include VitaminE rich foods in your diet? much love.
–
Reference:
Neurology Now (January 14, 2014)
Dysken, M.W. (2014). Journal of the American Medical Association.
We have been told the benefits of caffeine (see more info HERE).
What researchers are finding is that caffeine, the world’s most widely used drug, does more than wake people up. Caffeine is linked to improvements in memory and appears to protect against the destruction of brain cells. One of the results find that people who drank two or more cups of coffee a day had a 40 percent lower risk of developing Parkinson’s.
Because of these findings, some companies have been designing drugs to replicate the benefits of caffeine. The challenge is to go beyond the buzz of caffeine to achieve a more powerful effect on the brain — without side effects like headaches, irritability and jitters. But this hasn’t been easy. For example, Merck ended development of such a treatment for Parkinson’s disease last year after late-stage testing suggested it didn’t work. Other developers have postponed plans.
There is no cure for Parkinson’s. Drug developers are focusing on the way caffeine targets sites in an area deep in the brain called the basal ganglia, which is affected by Parkinson’s and plays a key role in movement. The medicines specifically aims to target and block adenosine A2A receptors. The goal of drug-makers is to improve movement in Parkinson’s; existing treatments become less effective over time, and side effects harder to endure.
… what are your thoughts on a “coffee pill” for the brain? Do you consume caffeine? much love.
–
more information and adapted from: bloom.bg/1gGePNm
afternoon hike at Witty’s Lagoon
misty afternoon at Sombrio Beach
Cherry Blossoms!
Cherry Blossoms!
afternoon home practice – working on a new perspective
